£5.0M
Eos Advisory led the Series A round alongside new and existing backers to fund international expansion and commercialisation.
D
Dxcover
Dxcover develops multiomic spectral analysis technology for early cancer detection.
£14.7MTotal raised
Dxcover is a clinical stage diagnostics company developing multiomic spectral analysis technology for the early detection of solid tumor cancers.
Categories
Founders
MB
Matthew Baker
Co-Founder, CEO and President
DP
David Palmer
Chief Scientific Officer
HB
Holly Butler
Chief Technical Officer
Investors
- £5.0M
- £9.7M
Funding history
£9.7M
Dxcover raises £9.7m in a Series A round and grant funding to advance its cancer detection platform.
The funding round was backed by a group of existing investors alongside a grant from the European Innovation Council.